RSS

funding

Funding for a series of ambitious technology projects set to transform drug discovery has been announced by business secretary, Greg Clark. more

News

The Association of the British Pharmaceutical Industry (ABPI) has released a thought piece looking at the UK’s increasing role in the fight against antimicrobial resistance (AMR). more

Opinion

A review into business productivity and funding for new schemes to boost the UK’s performance in delivering higher wages for people across the country has been announced by the chancellor. more

News

Innovative biotechnology company, ADC Biotechnology, has secured £1.14 million in funding from Downing LLP to assist the company in its US expansion and aid in the development of an advanced bioconjugation method. more

News

The specialist Liverpool based chemical intermediates company, Liverpool Chirochem (LCC), has raised £1.5 million in equity finance to support growth plans and increase production capacity overseas. more

News

Contract CRO, Aptus Clinical, is to be one of 12 partners to receive government funding that will be used to ensure more patients benefit from a new generation of disease-fighting medicines for cancer and non-cancer illnesses more

News

A £2 million funding round has been completed that will enable drug delivery company, Bio-Images Drug Delivery (BDD) to scale up its business to allow GMP manufacture of its OralogiK precision timed drug delivery system — ‘pill within a pill’. more

Technology

Biotech company, BCI Pharma, has received €3.9 million in private and public funding, which will be used to accelerate and finalise its research projects in the fields of cancer, neuropathic pain, inflammation and neuro-inflammation. more

News

Diagnostics company, Owlstone Medical, has raised $15 million to drive the global commercialisation of its Breath Biopsy platform. more

News

NHS funded initiative, SBRI Healthcare, has revealed its latest round of development awards, with 10 companies set to share a £1 million investment to develop innovations for high potential cancer screening solutions. more

News

Specialist in data discovery, knowledge graphs, search and data interaction, Siren, has completed a seed round worth €3 million, which it will use to bring its semantic data investigation platform to new sectors, including life sciences. more

Technology

UK-based biotechnology company, Stabilitech Biopharma, has received further funding from Innovate UK to develop its oral Zika virus vaccine so that it is first-in-human ready by 2020. more

News

A series A round of fundraising totalling over €1 million has been closed by VitriCell, a biotech company, which will enable the launch of products based on a new cell cryopreservation method, aseptic vitrification. more

Technology

Biotechnology company, Pherecydes Pharma, has raised €8.7 million in a Series B round of funding, which it plans to use to support the production of phages for compassionate use in accordance with good manufacturing practuces (GMP). more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Pharmacy Research UK (PRUK) — a research charity that supports pharmacists and pharmacy research — has announced the opening of its funding round for 2018 personal research awards and training bursaries. more

News

Biotechnology company, VirionHealth, has won non-dilutive funding from the US Defense Advanced Research Projects Agency (DARPA) to support development of its new class of biological antivirals. more

News

European life sciences investment group, LSP has successfully raised €280 million in funding, which will be used to invest in private companies with innovative healthcare products in the field of medical devices, diagnostics and digital health. more

News

Medherant — a company focused on transdermal drug delivery — has revealed that it has raised £3.8 million in its latest funding round, which will support the company as it progresses its ibuprofen TEPI Patch into clinical development early next year more

News

Clinical stage biopharmaceutical company, X4 Pharmaceuticals, has secured $27 million in series B funding that will be used to advance its two lead drug candidates in clinical efficacy studies in immune-oncology and a pivotal study in a rare disease. more

News